153 related articles for article (PubMed ID: 3734129)
1. Mass spectrometry: recent developments.
Markey SP
J Clin Pharmacol; 1986; 26(6):406-11. PubMed ID: 3734129
[No Abstract] [Full Text] [Related]
2. Imaging and spatially resolved quantification of drug distribution in tissues by mass spectrometry.
Prideaux B; Lenaerts A; Dartois V
Curr Opin Chem Biol; 2018 Jun; 44():93-100. PubMed ID: 29957376
[TBL] [Abstract][Full Text] [Related]
3. Current developments in LC-MS for pharmaceutical analysis.
Lim CK; Lord G
Biol Pharm Bull; 2002 May; 25(5):547-57. PubMed ID: 12033491
[TBL] [Abstract][Full Text] [Related]
4. Liquid chromatography-mass spectrometry coupling and its application in pharmaceutical research.
Vekey K; Edwards D; Zerilli LF
J Chromatogr; 1989 Mar; 488(1):73-85. PubMed ID: 2654166
[TBL] [Abstract][Full Text] [Related]
5. Chiral liquid chromatography-tandem mass spectrometric methods for stereoisomeric pharmaceutical determinations.
Chen J; Korfmacher WA; Hsieh Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(1):1-8. PubMed ID: 15866486
[TBL] [Abstract][Full Text] [Related]
6. Drug analysis by continuously monitored liquid chromatography/mass spectrometry with a quadrupole mass spectrometer.
Henion JD
Anal Chem; 1978 Oct; 50(12):1687-93. PubMed ID: 717783
[No Abstract] [Full Text] [Related]
7. Tandem mass spectrometry: the competitive edge for pharmacology.
Fenselau C
Annu Rev Pharmacol Toxicol; 1992; 32():555-78. PubMed ID: 1605578
[No Abstract] [Full Text] [Related]
8. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
Tolonen A; Turpeinen M; Pelkonen O
Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
[TBL] [Abstract][Full Text] [Related]
9. Detection of metabolites using high-performance liquid chromatography and mass spectrometry.
McClure TD
Curr Protoc Toxicol; 2001 May; Chapter 4():Unit4.4. PubMed ID: 20945295
[TBL] [Abstract][Full Text] [Related]
10. Frontiers in biological mass spectrometry.
Brancia FL
Comb Chem High Throughput Screen; 2009 Feb; 12(2):124. PubMed ID: 19199881
[No Abstract] [Full Text] [Related]
11. Mass spectrometry analysis of new chemical entities for pharmaceutical discovery.
Fang AS; Miao X; Tidswell PW; Towle MH; Goetzinger WK; Kyranos JN
Mass Spectrom Rev; 2008; 27(1):20-34. PubMed ID: 18033735
[TBL] [Abstract][Full Text] [Related]
12. Metabolite identification by mass spectrometry: forty years of evolution.
Wright P
Xenobiotica; 2011 Aug; 41(8):670-86. PubMed ID: 21434771
[TBL] [Abstract][Full Text] [Related]
13. Recent applications of mass spectrometry in pharmaceutical research.
Horváth G
Prog Drug Res; 1974; 18():399-473. PubMed ID: 4453610
[No Abstract] [Full Text] [Related]
14. Applications of mass spectrometry in drug metabolism: 50 years of progress.
Wen B; Zhu M
Drug Metab Rev; 2015 Feb; 47(1):71-87. PubMed ID: 25639893
[TBL] [Abstract][Full Text] [Related]
15. Accurate-mass instrumentation should not always be the first-and-only choice for MS in the drug metabolism environment.
Weston DJ; Beattie IG
Bioanalysis; 2011 Aug; 3(16):1795-8. PubMed ID: 21877886
[No Abstract] [Full Text] [Related]
16. Bioanalytical method development: considering information from a suite of complementary methods.
Fountain ME
Bioanalysis; 2012 Jan; 4(2):115-9. PubMed ID: 22250793
[No Abstract] [Full Text] [Related]
17. Advances in bioanalytical LC-MS using the Orbitrap™ mass analyzer.
Scigelova M; Makarov A
Bioanalysis; 2009 Jul; 1(4):741-54. PubMed ID: 21083136
[TBL] [Abstract][Full Text] [Related]
18. Young Investigator: Anderson Rodrigo Moraes de Oliveira.
De Oliveira AR
Bioanalysis; 2009 Jul; 1(4):697-8. PubMed ID: 21083130
[No Abstract] [Full Text] [Related]
19. Determination methods for biologically active compounds by ultra-performance liquid chromatography coupled with mass spectrometry: application to the analyses of pharmaceuticals, foods, plants, environments, metabonomics, and metabolomics.
Toyo'oka T
J Chromatogr Sci; 2008 Mar; 46(3):233-47. PubMed ID: 18334090
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry imaging in drug development.
Nilsson A; Goodwin RJ; Shariatgorji M; Vallianatou T; Webborn PJ; Andrén PE
Anal Chem; 2015 Feb; 87(3):1437-55. PubMed ID: 25526173
[No Abstract] [Full Text] [Related]
[Next] [New Search]
